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BipC, a Predicted Burkholderia
pseudomallei Type 3 Secretion
System Translocator Protein with
Actin Binding Activity
Charles W. Vander Broek, Nurhamimah Zainal Abidin and Joanne M. Stevens*
The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Scotland, United Kingdom
Burkholderia pseudomallei is an intracellular bacterial pathogen and the causative agent
of melioidosis, a severe disease of humans and animals. Like other clinically important
Gram-negative bacteria, fundamental to B. pseudomallei pathogenesis is the Bsa Type III
Secretion System. The Bsa system injects bacterial effector proteins into the cytoplasm of
target host cells subverting cellular pathways for the benefit of the bacteria. It is required
for invasion of non-phagocytic host cells, escape from the endocytic compartment into
the host cell cytoplasm, and for virulence in murine models of melioidosis. We have
recently described the repertoire of effector proteins secreted by the B. pseudomallei
Bsa system, however the functions of many of these effector proteins remain an enigma.
One such protein is BipC, a homolog of the translocator/effector proteins SipC and
IpaC from Salmonella spp. and Shigella flexneri respectively. SipC and IpaC each have
separate and distinct roles acting both as translocators, involved in creating a pore
in the eukaryotic cell membrane through which effector proteins can transit, and as
effectors by interacting with and polymerizing host cell actin. In this study, pull-down
assays demonstrate an interaction between BipC and actin. Furthermore, we show
that BipC directly interacts with actin, preferentially with actin polymers (F-actin) and
has the ability to polymerize actin in a similar manner as that described for SipC. Yet
unlike SipC, BipC does not stabilize F-actin filaments, indicating a functionally distinct
interaction with actin. Expression of Myc-tagged BipC in HeLa cells induces the formation
of pseudopodia similar to that seen for IpaC. This study explores the effector function of
BipC and reveals that actin interaction is conserved within the BipC/SipC/IpaC family of
translocator/effector proteins.
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INTRODUCTION
Burkholderia pseudomallei is a Gram-negative saprophyte found in the environment in soil and
standing water of Southeast and South Asia, tropical Australia, Western sub-Saharan Africa, and
South America. It is the causative agent of melioidosis, a severe disease of both humans and
animals (reviewed in Currie, 2015). Melioidosis is an emerging disease predicted to be vastly
underreported, with an estimated 165,000 cases of human melioidosis per year resulting in 89,000
deaths (Limmathurotsakul et al., 2016). There is currently no effective vaccine for melioidosis
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and treatment options are limited due to intrinsic antimicrobial
resistance mechanisms (reviewed in Schweizer, 2012). B.
pseudomallei is a facultative intracellular pathogen capable
of invasion of both phagocytic and non-phagocytic cells
(Pruksachartvuthi et al., 1990; Jones et al., 1996) which is followed
by rapid escape from the endosome (Harley et al., 1998b). Once
in the cytosol, the bacterium is capable of polymerizing host cell
actin to move both within and between cells by a process known
as actin-based motility (Kespichayawattana et al., 2000; Stevens
M. P. et al., 2005), as well as fusing together host cell membranes
causing the formation multi-nucleated giant cells (Harley et al.,
1998a; Kespichayawattana et al., 2000).
One important virulence factor which plays key roles in the
B. pseudomallei intracellular lifestyle is the Type III Secretion
System (T3SS) (reviewed in Sun and Gan, 2010). The T3SS
functions as a molecular syringe, allowing delivery of proteins
from the bacterial cytosol directly into the cytoplasm of a target
host cell, where they subvert host cell functions for the benefit of
the bacteria (reviewed in Büttner, 2012). Consisting of around
20 individual structural and regulatory proteins, T3SSs are a
key virulence factor in a range of clinically and economically
important pathogenic Gram-negative bacteria, such as Yersinia
spp., Salmonella spp., Shigella flexneri, Escherichia coli, and
Burkholderia spp. (reviewed in Coburn et al., 2007).
The genome of B. pseudomallei encodes three T3SSs
(Winstanley and Hart, 2000; Attree and Attree, 2001; Rainbow
et al., 2002). T3SS-1 and T3SS-2 are members of the Hrp
family of T3SSs found in bacterial pathogens of plants (Rainbow
et al., 2002). T3SS-3, also known as the Burkholderia secretion
apparatus (Bsa) T3SS, is a member of the Inv-Mxi-Spa family
of T3SSs from Salmonella spp. (SPI-1) and S. flexneri (Attree
and Attree, 2001; Stevens et al., 2002; Egan et al., 2014). The
Bsa system is required for full virulence in a murine model of
melioidosis (Stevens et al., 2004; Burtnick et al., 2008). In Shigella
and Salmonella, T3SSs are involved in cellular invasion followed
by either rapid escape into the cytosol (Shigella) or alteration
of the phagosome to provide a replicative niche (Salmonella)
(reviewed in Gruenheid and Finlay, 2003). Similarly, the B.
pseudomallei Bsa T3SS is required for efficient invasion of host
cells (Stevens et al., 2003; Muangsombut et al., 2008) and escape
from the phagosome (Stevens et al., 2002; Burtnick et al., 2008;
Muangsombut et al., 2008).
Recently we characterized the repertoire of proteins secreted
by the Bsa T3SS system using quantitative proteomics and
identified two novel effector proteins, BprD and BapA, as well
as six proteins that had previously been predicted or identified
as being secreted in a Bsa-dependent manner (Vander Broek
et al., 2015). Yet, in comparison to Shigella and Salmonella, the
functions of many of the effector proteins secreted by the Bsa
T3SS remain poorly characterized. One such protein is BipC,
which together with BipB likely function as translocator proteins
of the Bsa T3SS (Vander Broek et al., 2015). T3SS translocator
proteins are responsible for forming a pore in the eukaryotic
cell membrane allowing the injection of effector proteins into
the cytoplasm, which in the case of the Inv-Mxi-Spa family of
T3SSs, requires two distinct proteins (reviewed in Büttner, 2012).
BipC shares homology with the SipC and IpaC translocator
proteins of Salmonella and Shigella spp. respectively. Though
SipC and IpaC are both bacterial translocators, they also have
secondary effector functions, with the ability to directly bind
and polymerize host cell actin (Hayward and Koronakis, 1999;
Terry et al., 2008). SipC was first shown to directly interact with
actin by Hayward and Koronakis (1999). SipC has the ability
to polymerize actin as well as bundle F-actin in the absence of
host cell proteins (Hayward and Koronakis, 1999; McGhie et al.,
2001), and this activity is dependent on the C-terminal half of
the 409 amino acid protein (Chang et al., 2005; Myeni and Zhou,
2010). In order to efficiently polymerize actin SipC forms either
dimers ormultimers (Chang et al., 2007), and another bacterially-
encoded actin-binding protein, SipA, stabilizes actin filaments
and enhances the polymerization function of SipC (McGhie et al.,
2001). The actin polymerization domain of SipC has also been
demonstrated to be separate and functionally distinct from the
domain required for translocation (Myeni and Zhou, 2010).
Shigella IpaC also induces actin polymerization when expressed
or microinjected into cells (Van Nhieu et al., 1999) and the C-
terminus of the protein nucleates actin (Terry et al., 2008). It is
clear that IpaC and SipC are multi-functional proteins which play
important roles in intracellular life, leading to the hypothesis that
BipC may also have distinct roles beyond that of a translocator
protein.
In this study, we provide evidence of a direct interaction
between BipC and actin. We also demonstrate that BipC has
the ability to polymerize actin in vitro. HeLa cells expressing
N-terminal Myc-tagged BipC were morphologically distinct,
displaying multiple pseudopodia suggestive of subversion of
the host cell actin cytoskeleton. We clearly show that BipC
preferentially binds F-actin, but in contrast to SipC it does
not stabilize F-actin under depolymerizing conditions. This
study furthers our understanding of the function of BipC in
B. pseudomallei pathogenesis beyond its role as a Bsa T3SS
translocator.
METHODS
Bacterial Strains, Plasmids, and Culture
Media
Bacterial strains and plasmids are listed in Table S1. Bacteria
were routinely cultured at 37◦C on LB agar (Miller) or LB broth
(Lennox). Antibiotic selection was performed using ampicillin
(Amp) at 100 µg/ml unless otherwise stated. Isopropyl-β-D-
thiogalactopyranoside (IPTG) was used at a final concentration
of 0.2mM where appropriate. Eukaryotic tissue culture was
performed at 37◦C in the presence of 5% CO2. HeLa cells
were cultured in Dulbecco’s Modified Eagle Medium (DMEM,
Gibco) supplemented with 10% heat-inactivated fetal calf serum
(FCS), 1% L-glutamine, 100 units/ml penicillin, and 100 µg/ml
streptomycin.
Preparation of Glutathione
S-Transferase-Fusion Proteins
To create N-terminal glutathione S-transferase (GST)-fusion
proteins, the full length genes encoding BipC (B. pseudomallei
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10276) and SipC (S. enterica serovar Typhimurium 4/74) were
amplified from genomic DNA, cloned into the vector pGEX-4T-
1, propagated in E. coli XL1 Blue (Agilent) and then confirmed
by Sanger sequencing (Source Bioscience). pGEX-BimA48−384
(Stevens M. P. et al., 2005) was used as a positive control in
relevant assays. pGEX, pGEX-BipC, -SipC, and -BimA48−384
were transformed into E. coli Rosetta Bl21 (Novagen). An
overnight culture of E. coli Rosetta BL21 containing pGEX,
pGEX-BipC, -SipC, or -BimA48−384 was used to inoculate
LB containing Amp followed by incubation for 3 h with
shaking at 37
◦
C. IPTG was added followed by incubation
overnight at 16
◦
C. The bacteria were collected by centrifugation
and lyzed with ice-cold lysis buffer [1% Octylthioglucoside,
200mM NaCl, 1mM EDTA, 20mM Tris Cl, 1mM DTT,
0.1% Triton X-100, 10 µl Lysonase Bioprocessing Reagent
(Merck)]. The insoluble fraction was removed by centrifuging
at 10,000 RCF. In the case of GST-SipC, the recombinant
protein was insoluble after induction. Insoluble GST-SipC
was purified from inclusion bodies and refolded using the
Novagen protein refolding kit according to the manufacturer’s
instructions.
For GST, GST-BimA, and GST-BipC, glutathione (GSH)-
linked Sepharose beads (GE Healthcare) were added to the
bacterial lysate and incubated at 4
◦
C for 1 h with agitation.
The beads were collected by centrifugation, washed extensively
with PBS followed by Re-suspension in an equal volume
of PBS. When necessary, GST-fusion proteins were eluted
in elution buffer (50mM reduced GSH, 50mM Tris, pH
8.0). The solution was dialyzed three times in PBS for a
minimum of 2 h each to remove the detergents and salts. The
dialyzed protein was concentrated using a 10 kDa cut-off spin
column and protein concentrations determined using a Direct
Detect (Merck Millipore).
Murine Splenic Lysate Pull-Downs
Murine spleens∗ were homogenized in 1x polymerization buffer
with protease inhibitors (10mM Tris—pH 7.5, 1mM ATP, 2mM
MgCl2, 50 mM KCl, 0.5 mM EGTA, 1 mM PMSF, 1 µg/ml
pepstatin A, 10 µg/ml leupeptin, 1 µg/ml aprotinin). Lysates
were clarified by ultracentrifugation at 100,000 RCF. To perform
pull downs, an aliquot of murine splenic lysate was diluted 1:3
with 1x polymerization buffer and CaCl2 was added to a final
concentration of 100 µM. The GST or GST-fusion proteins of
interest (-BimA48−384, -BipC, and -SipC) bound to GSH-linked
Sepharose beads were added to the lysate and incubated for 1 h at
room temperature with agitation. The Sepharose beads were then
washed five times with ice-cold PBS. Samples were subjected to
SDS-PAGE and visualized by Coomassie blue staining (Thermo
Fisher). For immunoblotting, proteins were transferred to
PVDF membranes and visualized using goat α-actin primary
antibody (Santa Cruz Biotechnology) followed by rabbit α-goat
HRP-linked secondary antibody (Invitrogen). The antibodies
were detected using ECL (Thermo Fisher) followed by film
exposure.
∗Tissues were obtained from wild-type mice in accordance
with the UK Animals (Scientific Procedures) Act 1986, following
local ethical review of protocols.
Rhodamine-Actin Binding Assay
Confocal microscopy was used to investigate the ability of GST-
fusion proteins to directly bind actin as described in (Stevens J.
M. et al., 2005; Stevens M. P. et al., 2005). To the center of a
glass microscope slide, 10 µl of 1x polymerization buffer or PBS
containing 1 µM rhodamine labeled actin was added. To this, 1
µl of the GST-fusion proteins of interest (GST, GST-BimA48−384,
or GST-BipC) bound to GSH-linked Sepharose beads was added.
The slide was immediately visualized using a Zeiss LSM 710
Scanning Laser Confocal Microscope using an excitation of
535 nm and an emission of 585 nm, and data collected using Zen
2011 software (Zeiss). Images were further processed using Image
J (https://imagej.nih.gov/ij/).
Actin Sedimentation Assay
Mg-actin was prepared by incubating 4µg/µl rhodamine-labeled
actin (Cytoskeleton) in the presence of 50 µM MgCl2, and 125
µM EGTA for 10 min at room temperature. To the mixture, 10x
polymerization buffer was added to a final concentration of 1x
and incubated for 2 h at room temperature to polymerize the
G-actin into F-actin. Sedimentation reactions were prepared in
G-Mg buffer (5mM Tris-HCl pH8, 0.2mMMgCl2, 0.2 mMATP,
0.5mM DTT) by adding 2.3 µM of F-actin and 1 µM of GST-
fusion protein. The reaction was incubated at room temperature
for 30 min in the dark before being centrifuged at 100,000 RCF
for 1 h at 20
◦
C to sediment the F-actin. The soluble fraction
(monomeric G-actin fraction) was separated from the pellet
(filamentous F-actin) and the fractions were re-suspended in 2x
Laemmli buffer, separated by SDS-PAGE and visualized using
Silver staining (Pierce Scientific) according to the manufacturer’s
protocol. Densitometry was performed using Image Studio Lite
software (LI-COR Biosciences).
Pyrene Actin Polymerization Assay
A pyrene actin polymerization assay was performed essentially
as previously described (Stevens et al., 2003). Samples were
excited with a wavelength of 365 nm and emission was collected
at a wavelength of 407 nm. Data was collected every 30 s
for up to 1 h using a FLUOstar Omega plate reader (BMG
Labtech). Monomeric actin was used in polymerization assays
at a final concentration of 2–3 µM and GST or GST-fusion
proteins were used at a final concentration of 1 µM. Each well
contained polymerization buffer at a final concentration of 1x.
The assay was performed in three independent replicates with
three technical measurements per replicate. Data were plotted
in Excel. The rates of polymerization were calculated as the
rise in fluorescence units per second during the linear phase
of polymerization, between 200 and 800 s. The mean rates
of polymerization for each protein were analyzed by pairwise
Student t-test using R software (https://www.r-project.org/) and
P-values of ≤ 0.05 were taken as significant.
Actin Depolymerization Assay
To assess the ability of BipC to stabilize actin filaments, an actin
depolymerization assay was performed essentially as previously
described (McGhie et al., 2001). Mg-actin was prepared by
incubating 1 mg/ml pyrene-labeled actin with 125 µM EGTA
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and 50 µM MgCl2 for 10min at room temperature. The Mg-
actin was then polymerized by adding 10x polymerization buffer
to a final concentration of 1x, followed by incubation at room
temperature in the dark for 2–4 h. The depolymerization assay
was set up in a 96 well black opaque plate with each well
containing 2.3 µM F-actin, plus or minus 2.5 µM of the GST-
fusion proteins. Data was collected every 30 s for up to 1 h
using a FLUOstar Omega plate reader (BMG Labtech), with
samples excited at 365 nm and emission data collected at 407 nm.
The assay was performed in three independent replicates with
two measurements per replicate. Data was plotted in Excel.
Relative fluorescence intensity was calculated by dividing all
of the sample measurements by its value at time = 0 s. The
rates of depolymerization were calculated as the decrease in
relative fluorescence units per second during the linear phase
of depolymerization, between 100 and 600 s. The mean rates
of depolymerization for each protein were analyzed by pairwise
Student t-test using R software (https://www.r-project.org/) and
P-values of ≤ 0.05 were taken as significant.
HeLa Cell Transfections and
Immunofluorescence Microscopy
In order to investigate the effects of ectopically expressed
BipC in eukaryotic cells, HeLa cells were transfected with
the constitutive eukaryotic expression vector pRK5-myc-BipC,
which encodes BipC with an in-frame N-terminal c-Myc
tag. The plasmid pEGFP (Clontech) which encodes enhanced
green fluorescent protein (EGFP) was used as a control. HeLa
cell transfections were performed using Lipofectamine 2000
(Invitrogen) according to the manufacturers protocol, using 4.0
µg of plasmid and 10 µl of Lipofectamine 2000 per well. The
transfected HeLa cells were incubated for 48 h before being fixed
in 4% paraformaldehyde in PBS. The cells were washed twice
with PBS and permeabilized using PBS containing 0.5% Triton
X-100 for 15 min. Cells were washed twice with PBS and then
blocked for 30 min with blocking buffer (PBS containing 0.5%
bovine serum albumin w/v, 0.02% NaN3 w/v). In order to detect
the Myc-BipC protein, cover slips were incubated with rabbit α-
c-Myc primary antibody (0.5 µg/ml, Santa Cruz) at 37
◦
C for 1
h. The cover slips were washed three times with PBS followed
by incubation with goat α-rabbit488 secondary antibody (10
µg/ml, Molecular Probes) for 1 h. The cover slips were washed
three times with PBS and incubated with phalloidin568 (10
µg/ml, Invitrogen) for 15 min. The cover slips were washed six
times with PBS, mounted and visualized using a Zeiss LSM 710
Scanning Laser Confocal Microscope using Zen 2011 software
(Zeiss). Images were processed using Image J software (https://
imagej.nih.gov/ij/).
RESULTS
BipC Directly Binds Cellular Actin
BipC (annotated as BPSS1531 in the reference K96243 genome)
is encoded within the Bsa T3SS locus and is very highly conserved
in pathogenic B. pseudomallei and B. mallei (100% identity),
and in the closely related avirulent B. thailandensis, though to
a lesser extent (86% identity). The B. thailandensis BipC protein
contains numerous single amino acid differences as well as two
minor deletions in comparison to the BipC proteins of the other
two species (Figure S1). BipC shares homology with SipC (58%
coverage and 24% identity at the amino acid level) and IpaC (58%
coverage, 22% identity) from Salmonella spp. and S. flexneri,
respectively (Figure S2). We previously identified BipC in the
secretome of B. pseudomallei using a quantitative proteomics
approach (Vander Broek et al., 2015). Due to the similarity in
sequence between BipC and SipC/IpaC, we hypothesized that
BipC would be an actin-binding protein and may possess the
ability to bundle F-actin. In the following experiments, we have
directly compared the activities of BipC with Salmonella SipC or
the B. pseudomallei BimA protein as positive controls. We have
previously characterized BimA, which is required for actin-based
motility of B. pseudomallei, as an actin monomer binding and
actin polymerizing factor (Stevens M. P. et al., 2005; Sitthidet
et al., 2011). Both SipC and IpaC interact with and nucleate
actin polymerization in vitro (Hayward and Koronakis, 1999;
Terry et al., 2008), facilitating bacterial invasion of host cells
(Mounier et al., 2009; Myeni and Zhou, 2010). In order to
investigate whether BipC associates with cellular actin, pull-down
experiments were performed using a GST-BipC fusion protein
and murine splenic lysates under actin polymerizing conditions.
In a similar manner to the control SipC and BimA proteins,
Figure 1A shows that BipC can interact with actin in a murine
splenic lysate. Because pull-downs may identify interactions
that are indirect through large protein complexes (reviewed
in Kool et al., 2011), further work was required to determine
if BipC has the ability to bind actin directly. To test this,
GSH-linked Sepharose beads coated with GST fusion proteins
were incubated with rhodamine-labeled actin, under either
polymerizing or non-polymerizing conditions (PBS), followed by
immediate visualization using a confocal microscope. A protein
that is able to directly bind actin creates a high concentration
of the rhodamine-labeled actin at the surface of the Sepharose
bead, which appears as a red “halo” or ring around the clear
bead in microscope images. The GST-BimA48−384 coated beads
directly bound actin in both polymerization buffer and PBS as
indicated by a distinct red halo (Figure 1B), and in agreement
with previous studies by our laboratory (Stevens J. M. et al., 2005;
Stevens M. P. et al., 2005; Sitthidet et al., 2011). The GST-BipC
coated beads also directly bound actin in both polymerization
buffer and PBS, but appeared to bind actin more efficiently under
polymerizing conditions (Figure 1B). At the time of submission
of this manuscript for peer review we believed this to be the first
evidence that BipC is an actin-binding protein. However, we have
since become aware of a similar study by Kang et al. (2016), which
also demonstrates that B. pseudomallei BipC is an actin-binding
protein.
As BipC appeared to bind actin more efficiently under
polymerizing conditions, we were interested in testing whether
it preferentially binds to F-actin or G-actin using a quantitative
sedimentation assay as we have previously described (Stevens
M. P. et al., 2005). Purified GST and GST-fusion proteins (GST-
BipC, GST-SipC, and GST-BimA48−384) were pre-incubated
with polymerized actin (F-actin). Ultra-centrifugation was then
used to sediment the F-actin along with any interacting GST
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FIGURE 1 | B. pseudomallei BipC interacts with cellular actin. (A) GST-BipC interacts with actin in murine splenic lysates. GST, GST-BimA48−384, GST-SipC, and
GST-BipC bound to GSH-linked Sepharose beads were incubated with murine splenic lysates in polymerization buffer. The Sepharose beads were washed and the
bound proteins were denatured in Laemmli buffer. The Coomassie stained gel shows the relative quantities of input proteins used in the pull-down assay. Equal
volumes (5 µl) of each pulldown sample (representing a half of the total samples) were analyzed by SDS-PAGE and Western blot. The α-actin Western blot indicates
actin binding to the fusion proteins. (B) GST-BipC directly interacts with actin in the absence of other cellular proteins. GSH-Sepharose beads coated with either GST,
GST-BimA48−384,or GST-BipC were mixed with rhodamine-labeled actin suspended either in polymerization buffer or PBS and immediately imaged using a confocal
microscope. The formation of a red “halo” around the bead indicates binding of actin to the bead surface. These are also shown as grayscale images for clarity.
DIC/phase contrast images of the beads are also shown. Scale bar = 20 µm. (C) GST-BipC preferentially binds F-actin. Actin was allowed to polymerize at room
(Continued)
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FIGURE 1 | Continued
temperature for 2 h before being mixed with GST, GST-BimA48−384, GST-SipC, or GST-BipC. The mixtures were submitted to ultra-centrifugation to separate the
monomeric actin (supernatant) and the filamentous actin (pellet). Proteins in the supernatant (S) and pellet (P) fractions were separated by SDS-PAGE and visualized
by silver staining. The GST-fusion proteins are indicated by the blue arrows. The average percentage and standard deviation over the three replicates of each
GST-fusion protein distributed in the supernatant or pellet (as determined by densitometry) is shown below the corresponding lane in the image (shown as %).
fusion protein. Under these conditions the monomeric G-
actin, along with any G-actin interacting proteins or with non-
interacting proteins (such as GST), remain in the supernatant.
The supernatants and pellets were then subjected to SDS-PAGE
and visualized by silver staining. Densitometry was used to
quantify the levels of protein present in each sample. Three
independent replicates of the assay were performed to ensure
reproducibility. As a control, the assay was also performed in the
absence of actin to demonstrate that the GST proteins would not
sediment on their own (Figure S3). As expected the GST protein
was primarily present in the supernatant fraction as it does not
possess actin binding activity (Figure 1C). GST-BimA48−384 was
alsomost abundant in the supernatant fraction due to its intrinsic
G-actin binding activity (Figure 1C), and in concordance with
our previous published observation (Stevens M. P. et al., 2005).
GST-SipC associated predominantly with the pellet fraction due
to its preferential binding to F-actin, which is in agreement with
data published by Hayward and Koronakis (1999) (Figure 1C).
Similarly, GST-BipC also co-sedimented with the F-actin pellet in
this assay, indicating that it too preferentially binds F-actin under
these conditions (Figure 1C).
We have recently investigated the interaction of B.
pseudomallei BimA with cellular proteins using a yeast
two-hybrid assay (Jitprasutwit et al., 2016). Whilst we have been
able to confirm that BimA is an actin-interacting protein in
this assay (Jitprasutwit et al., 2016), we were unable to detect a
direct interaction between BipC and actin by yeast two-hybrid
assay (Figure S4). In our assay, the BipC protein was fused to the
GAL4 DNA-binding domain and actin was fused to the GAL4
activation domain. It is possible that the fusion of BipC to the
GAL4 DNA-binding domain affected the tertiary structure of
the protein and disrupted the interaction. It is also a possibility
that the actin-GAL4 fusion protein is unable to polymerize into
F-actin, which we have demonstrated that BipC predominantly
associates with (Figure 1C). In support of this hypothesis,
we have been unable to find examples of the use of the yeast
two-hybrid system to dissect interactions of F-actin binding
proteins with actin in the literature.
BipC Polymerizes Actin In vitro
Previous work has demonstrated that Salmonella SipC not only
has the ability to bind and bundle F-actin, but also to polymerize
actin (Hayward and Koronakis, 1999). To determine if BipC
is also able to polymerize actin, a polymerization assay was
performed with pyrene-labeled actin, which emits fluorescence
over time as monomers assemble into actin filaments (Stevens
M. P. et al., 2005). GST, GST-SipC, and GST-BipC were incubated
with pyrene actin in polymerization buffer and their rates of actin
polymerization compared by measuring fluorescence intensity
over time. SipC showed a statistically significant increased rate of
polymerization (average rate of increase in fluorescence intensity
= 14.66 ± 5.01 AU/s) when compared to the GST control which
mimics the rate of intrinsic actin polymerization in the absence
of a polymerizing factor (average rate of increase in fluorescence
intensity = 7.45 ± 3.65 AU/s) (Figure 2A). BipC also showed a
statistically significant increase in the rate of actin polymerization
(average rate of increase in fluorescence intensity = 9.88 ± 3.87
AU/s) when compared to the GST control indicating that this
protein has an intrinsic actin polymerizing activity (Figure 2A).
With the establishment that BipC binds and polymerizes
actin in vitro, we wanted to investigate what effect BipC
would have when expressed ectopically in eukaryotic host
cells. Full length BipC was transiently expressed with an in-
frame N-terminal c-Myc tag in HeLa cells. At 48 h post-
transfection, the cells were fixed and permeabilized, probed
using phalloidin (to label F-actin) and rabbit α-Myc antibodies
to label BipC, and imaged using a confocal microscope.
In cells expressing BipC, the BipC protein localized around
the periphery of the cells (Figure 2B). The cells expressing
BipC were morphologically distinct from untransfected cells,
displaying multiple pseudopodia-like structures, indicating that
BipC modulates actin dynamics within host cells (Figure 2B).
BipC Lacks the Ability to Stabilize F-actin
In addition to stimulating the polymerization of actin in vitro,
Salmonella SipC also stabilizes F-actin polymers, preventing
their dissociation in solution. The actin polymerizing and F-
actin bundling activities of SipC are enhanced by another
T3SS effector protein, SipA (McGhie et al., 2001). Interestingly,
there is no direct homolog of SipA encoded by the B.
pseudomallei genome. To investigate whether BipC has the
ability to stabilize F-actin polymers in its own right, an actin
depolymerization assay was performed. The inverse of the
polymerization assay, the depolymerization assay measures a
reduction in the rate of relative fluorescence over time as
pyrene-F-actin filaments disassemble into actin monomers (G-
actin). GST, GST-SipC, or GST-BipC were incubated with pre-
polymerized pyrene-actin under depolymerizing conditions and
fluorescence intensity was measured over time. As expected, the
GST negative control showed similar levels of depolymerization
to that of the actin-only control since it lacks any actin-
binding or F-actin stabilizing activities (Figure 2C). Under
the same assay conditions F-actin incubated with SipC was
significantly stabilized and showed significantly slower rates of
depolymerisation, as previously demonstrated by McGhie et al.
(2001). Surprisingly we did not need to include recombinant
SipA in our assay, although addition of SipA may well
have further enhanced the F-actin stabilizing activity of SipC.
In contrast the GST-BipC protein showed no significant F-
actin stabilizing activity in this assay, demonstrating that this
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FIGURE 2 | BipC demonstrates actin polymerization, but not F-actin stabilizing activities. (A) BipC stimulates actin polymerization in vitro. GST, GST-SipC, and
GST-BipC were mixed with monomeric pyrene-actin in actin polymerization buffer. The polymerization assay was monitored every 30 s for 40 min with an excitation
wavelength of 365 nm and an emission wavelength of 407 nm. The rate of polymerization was calculated between 200 and 800 s. The graph shows one
representative experiment, while the table insert shows data accumulated from three independent experiments, each consisting of three technical replicates. (B)
Ectopic expression of Myc-tagged BipC alters cell morphology. HeLa cells were transfected with pRK5-Myc-BipC and fixed in paraformaldehyde 48 h
post-transfection. Following permeabilization, cells were probed using phalloidin and rabbit α-c-Myc antibodies, and imaged using a confocal microscope. HeLa cells
transfected with pEGFP were also imaged. In the merged representative images, the actin cytoskeleton stained with phalloidin appears red, and Myc-BipC or pEGFP
appear green. Pseudopodia-like structures are indicated by the white arrows. (C) BipC lacks F-actin stabilization activity. GST, GST-BipC, and GST-SipC were
incubated with pyrene labeled F-actin. Fluorescence was measured for 40 min in 30 s intervals with an excitation wavelength of 365 nm and an emission wavelength
of 407 nm. The rate of depolymerization was calculated between 100 and 600 s. The graph shows one representative experiment. The table insert shows the
accumulated data from three independent experiments, each consisting of two technical replicates.
protein, unlike its homolog SipC, does not have intrinsic F-
actin bundling activity (Figure 2C). Since submission of this
manuscript for peer review, a study by Kang et al. (2016)
suggested that a His-tagged BipC protein exhibited F-actin
stabilizing activity in a similar assay. However, it is notable that
much higher concentrations of BipC protein were required in
these experiments than used in our study, or that of McGhie et al.
(2001).
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DISCUSSION
The B. pseudomallei BipC protein is homologous to the
Salmonella SipC and Shigella IpaC T3SS proteins, and is secreted
by the Bsa T3SS (Stevens et al., 2002; Vander Broek et al., 2015).
A predicted translocator protein, BipC is highly conserved in all
B. pseudomallei, B. mallei and B. thailandensis strains sequenced
to date. The cognate translocator protein responsible for pore
formation in the eukaryotic cell membrane is known as BipB.
Both BipB and BipC are potent B-cell antigens (Felgner et al.,
2009), however, BipC recombinant proteins failed to demonstrate
efficacy as subunit vaccines in murine models of melioidosis
(Druar et al., 2008). A recent study demonstrated that a bipC
insertion mutant was attenuated in a BALB/c mouse model of
melioidosis, showed significant defects in host cell adhesion,
invasion, phagosome escape and intracellular replication (Kang
et al., 2015). Similar findings have been reported upon ablation
of the bipB gene (Suparak et al., 2005). While the Kang
study (2015) shows a clear role of BipC in virulence and the
intracellular lifestyle of the bacterium, it does not separate BipC’s
role as a translocator (necessary for a functional T3SS) from
additional roles it may have as an effector protein. Here we have
sought to characterize the effector function of BipC in relevant
biochemical assays utilizing our knowledge of the effector
functions of the homologous Salmonella SipC and Shigella IpaC
proteins.
Both SipC and IpaC bind and nucleate actin (Hayward and
Koronakis, 1999; Terry et al., 2008), facilitating bacterial invasion
of host cells (Mounier et al., 2009; Myeni and Zhou, 2010).
The actin nucleation domain of IpaC has been identified as
the C-terminal 20 amino acids (Terry et al., 2008), an area
relatively more highly conserved in BipC (Figure S2). Here we
have demonstrated that GST-BipC has the ability to bind actin
directly, in the absence of other bacterial or cellular proteins.
We acknowledge that whilst our study was in review, Kang
et al. (2016) published similar observations to those presented
in our manuscript. However, upon closer inspection there is
only a small amount of “overlap” with our data regarding
the function of BipC as an actin binding and polymerizing
factor. Kang et al. (2016) demonstrated that BipC interacts with
both monomeric and filamentous actin using a basic pulldown
assay, however there is no quantitation or inclusion of relevant
control proteins in their assay. What we add to this finding
is that BipC preferentially binds F-actin filaments, behaving
in a manner more similar to SipC than BimA (Stevens M.
P. et al., 2005; Myeni and Zhou, 2010). We believe we have
been significantly more thorough in our investigation of the
BipC: actin interaction and the ability of BipC to polymerise
actin in vitro, utilizing several different approaches and applying
quantification methods where appropriate. We also believe that
we have included relevant and pertinent controls in all of
the assays presented in this paper. In addition, a noteworthy
finding in our study was the inability of BipC to stabilize F-
actin, suggesting that its role in actin dynamics differs from
that of SipC. This may not be surprising as the ability of
SipC to bundle F-actin has been attributed to amino acids 1–
120 (Hayward and Koronakis, 1999) and 221–260 (Myeni and
Zhou, 2010), regions which are not well-conserved in BipC
(Figure S2).
Beyond its ability to directly bind actin, it was also
demonstrated that BipC polymerizes actin in vitro in the absence
of any other bacterial or cellular co-factors. In our hands, BipC-
mediated actin polymerization appeared to be less potent than
that displayed by SipC under the same assay conditions. Further
evidence in support of a role for BipC in polymerizing actin
was presented following ectopic expression of the protein in
eukaryotic host cells. The Myc-tagged BipC protein localized to
the cell membrane with F-actin and pseudopodia-like structures.
A similar phenotype has been described upon introduction of
recombinant IpaC into permeabilized Swiss 3T3 cells (Van Nhieu
et al., 1999), as well as inNIH3T3 cells ectopically expressing SipC
(Cain et al., 2004).
It has been hypothesized that the SipC/IpaC family of
translocator/effector proteins may play a pivotal role in
determining the intracellular niche of the bacteria. A Salmonella
sipC mutant can be complemented by both sipC or ipaC
expression in trans, but a Shigella ipaC mutant can only be
complemented by ipaC (Osiecki et al., 2001). The authors suggest
the different functions may parallel the different intracellular
lifestyles of the pathogens, with Salmonella residing within the
vacuole and Shigella rapidly escaping into the cytosol (Osiecki
et al., 2001). Indeed, this is supported by a recent study in
which Salmonella expressing ipaC was shown to be capable of
vacuole escape (Du et al., 2016). Because of closer parallels
between the intracellular lifestyles of B. pseudomallei and Shigella,
we would predict that BipC would function in a manner
more similar to IpaC than SipC, mediating the exit of the
bacterium from the endocytic compartment into the host cell
cytosol.
The differences between Salmonella and Shigella also extend
to other T3S actin modulating proteins. It has been shown
that the actin polymerization activity of SipC can be enhanced
by Salmonella T3SS effector protein SipA, but this activity
cannot be functionally complemented by the homologous
Shigella T3SS effector, IpaA (McGhie et al., 2001). IpaA has
instead been shown to bind cellular vinculin altering its
barbed end capping activity, causing depolymerisation of F-
actin at the site of bacterial entry (Van Nhieu et al., 1997;
Bourdet-Sicard et al., 1999; Ramarao et al., 2007; Park et al.,
2011). It is possible that other B. pseudomallei T3SS effector
proteins, that have yet to be identified, may work synergistically
with BipC to enhance actin polymerization or, similar to
IpaA, may affect cellular actin dynamics in some other
way.
Further work is now warranted to explore the mechanisms
by which BipC binds and nucleates actin, as well the
role this may play in B. pseudomallei pathogenesis. It is
tempting to speculate that the effector function of BipC is
involved in the invasion of host cells and/or the escape
from the phagosome. Nonetheless, it is clear that a better
understanding of B. pseudomallei pathogenesis is required
in order to facilitate the development of improved control
measures and alternative therapies for melioidosis in the
future.
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